Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$244 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$0 Mln
ROE
-2.3 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
28
Industry P/E
54.26
EV/EBITDA
-5.1
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$-0.5
Face value
--
Shares outstanding
40,632,367
CFO
$-38.51 Mln
EBITDA
$-42.81 Mln
Net Profit
$-51.49 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Monogram Orthopaedics Inc. (MGRM)
| 153.2 | 5.1 | 106.2 | 158.6 | -- | -- | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
|---|---|
|
Monogram Orthopaedics Inc. (MGRM)
| -30.9 |
|
S&P Small-Cap 600
| 7.0 |
|
BSE Sensex
| 8.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Monogram Orthopaedics Inc. (MGRM)
|
6.0 | 243.8 | 0.4 | -17.9 | -3,436.1 | -155 | -- | 28.0 |
| 5.0 | 215.2 | 0.0 | -26.2 | -211,400.0 | -- | -- | 36.6 |
As of October 7, 2025, Monogram Technologies Inc. was acquired by Zimmer Biomet Holdings, Inc.. Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. It... intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. The company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024. Monogram Technologies Inc. was founded in 2015 and is headquartered in Austin, Texas. Read more
Chairman of the Board, President & CEO
Mr. Benjamin Sexson C.F.A.
Chairman of the Board, President & CEO
Mr. Benjamin Sexson C.F.A.
Headquarters
Austin, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Monogram Orthopaedics Inc (MGRM) is $6.00 (NASDAQ) as of 08-Oct-2025 09:30 EDT. Monogram Orthopaedics Inc (MGRM) has given a return of 158.62% in the last 1 years.
Since, TTM earnings of Monogram Orthopaedics Inc (MGRM) is negative, P/E ratio is not available.
The P/B ratio of Monogram Orthopaedics Inc (MGRM) is 27.98 times as on 08-Oct-2025, a 848 premium to its peers’ median range of 2.95 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
-4.73
|
5.32
|
|
2023
|
-7.84
|
8.05
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
The 52-week high and low of Monogram Orthopaedics Inc (MGRM) are Rs 6.43 and Rs 1.92 as of 04-Apr-2026.
Monogram Orthopaedics Inc (MGRM) has a market capitalisation of $ 244 Mln as on 08-Oct-2025. As per SEBI classification, it is a Small Cap company.
Before investing in Monogram Orthopaedics Inc (MGRM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.